Factor XI anticorps

N° du produit ABIN7536708

Détail du produit anti-Factor XI anticorps

Antigène: Factor XI (F11) (Coagulation Factor XI (F11))

Reactivité: Humain

Hôte: Chèvre

Clonalité: Polyclonal

Conjugué: Cet anticorp Factor XI est non-conjugé

Application: Western Blotting (WB), ELISA, Immunoprecipitation (IP), Neutralization (Neut), Immunoelectrophoresis (IEP), Immunodepletion (IDe)

Fonction: Factor XI Polyclonal Antibody - Goat

Specificité: Human Factor XI, F11, FXI

Purification: Fractionation of IgG from antiserum

Immunogène: Human factor XI purified from plasma

Isotype: IgG

Information d'application

Indications d'application: Immunoblot 5-25 μg/mL, ELISA capture 20-50 μg/mL

Commentaires:

Whole IgG is a base level product and refers to IgG antibodies purified from antiserum using multiple precipitation and dialysis steps. The purity of the IgG is typically 90% and is provided in a solution of HEPES buffered saline containing 50% glycerol (v/v). The titre is essentially the same as the starting antiserum and each vial typically contains the amount of IgG recovered from one millilitre of antiserum. This level of product is generally intended for use in applications such as immunoprecipitation, immunoelectrophoresis, immuno-depletion and activity neutralization assays.

Restrictions: For Research Use only

Stockage

Format: Liquid

Reconstitution: Allow product to warm to room temperature and gently mix before use

Concentration: 5 mg/mL

Buffer: 10 mM HEPES, pH 7.4, 150 mM NaC, 50 % (v/v) glycerol

Stock: -20 °C

Stockage commentaire: Store between -10°C and -20°C

Détails sur Factor XI

Antigène: Factor XI (F11) (Coagulation Factor XI (F11))

Autre désignation: Factor XI (F11 Produits)

Synonymes: anticorps FXI, anticorps 1600027G01Rik, anticorps AI503996, anticorps Cf11, anticorps LRRGT00086, anticorps coagulation factor XI, anticorps F11, anticorps CpipJ_CPIJ000593, anticorps CpipJ_CPIJ001060, anticorps CpipJ_CPIJ002752, anticorps CpipJ_CPIJ003631, anticorps CpipJ_CPIJ004041, anticorps CpipJ_CPIJ004093